Kevin C. Zorn, MD, FRCSC, FACS presented “Overview of Current MIST: Practical Considerations ” during the 2023 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on November 10, 2023, in Chicago, Illinois.
How to cite: Zorn, Kevin C. “Overview of Current MIST: Practical Considerations ” November, 2023. Accessed Nov 2025. https://grandroundsinurology.com/overview-of-current-mist-practical-considerations/
Overview of Current MIST: Practical Considerations – Summary
Kevin C. Zorn, MD, FRCSC, FACS, provides an authoritative overview of current minimally invasive surgical techniques (MIST) for the treatment of benign prostatic hyperplasia (BPH). His analysis emphasizes the advancements in MIST and their role in providing effective and patient-friendly alternatives to traditional surgical approaches.
Dr. Zorn highlights the primary MIST options currently available, including transurethral resection of the prostate (TURP), photoselective vaporization of the prostate (PVP), holmium laser enucleation of the prostate (HoLEP), and newer techniques such as water vapor thermal therapy and prostatic urethral lift (PUL). The procedural nuances of each MIST option are discussed in detail.
Dr. Zorn examines the outcomes and benefits of MIST as well as the challenges and limitations of the procedures. Future directions in MIST are considered, with Dr. Zorn highlighting ongoing research and innovation to further refine these techniques and expand their applicability. The integration of advanced imaging technologies and the development of novel therapeutic devices hold promise for enhancing the precision and effectiveness of MIST.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
ABOUT THE AUTHOR
Kevin C. Zorn, MD, FACS, FRCSC, is the Founder and Director at BPH Canada Prostate Institute in Montréal, Canada. Dr. Zorn also serves as Director of Urology and BPH Prostate MIS Surgery at the Centre de chirurgie Mont-Royal. His main focus of clinical and scientific interest is the surgical treatment of renal and prostate cancer. He is also an expert in performing surgery with the daVinciⓇSurgical Robotic System to manage localized prostate cancer and small renal masses.
Dr. Zorn attended McGill University in Montréal for his pre-med program, his medical degree, and his residency in Urological Surgery. He became a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCSC) in 2005. Dr. Zorn also completed a fellowship in oncology and endourology at the University of Chicago. In 2007, he became certified by the American Board of Urology in urology and a Fellow of the American College of Surgeons.
Dr. Zorn was the first in Canada to use many new BPH technologies, including Greenlight XPS, Rezum, iTind, Optilume, Aquablation, and Zenflow. He has also been the first in Canada to introduce cutting-edge technologies, including the Clarius and ButterflyIQ point-of-care ultrasound (POCUS), as well as disposable AMBU4 cystoscopes for faster patient care and greater safety. Dr. Zorn is among the first physicians globally to be named as a Center of Excellence for Rezum and Greenlight vaporization and VIT (vapor incision technique). He is an international speaker and surgical trainer for these techniques.
Dr. Zorn is the senior author of theMale Lower Urinary Tract Symptoms (LUTS)/BPH Guidelinesfor the 2018 and 2022 Canadian Urological Association (CUA) and consulted on the American Urological Association BPH guidelines. He has also helped create national online programs in robotic prostate cancer care and rehabilitation, as well as the CUA BPH patient decision-aid tool. Dr. Zorn has authored 400 peer-reviewed publications and 12 book chapters on BPH and minimally invasive surgical care.
